Insider · CIK 0001914936
Mark Leonard Singleton
Files at BVS (Bioventus Inc.). First filing Dec 26, 2024, latest Apr 15, 2025.
In brief
Mark Leonard Singleton files SEC Form 4 as CFO at BVS (Bioventus Inc.). Since Dec 26, 2024, Mark Leonard Singleton has reported 0 open-market buys worth $0 and 4 open-market sells worth $262k, the latest filed on Apr 15, 2025.
A track record needs three past buys with six months of prices behind them; Mark Leonard Singleton has 0, so none is measured yet.
The newest scored trade: sold $29k of BVS on Apr 11, 2025, filed Apr 15, 2025, scored 22 (weak), under a 10b5-1 plan.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
BVS: Bioventus Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 22Weak | Bioventus Inc. | $29k 3,875 shares | -3% | 0% from low-45% from high | |
| 24Weak | Bioventus Inc. | $54k 5,479 shares | -4% | - | |
| 25Weak | Bioventus Inc. | $66k 6,498 shares | -5% | - | |
| 27Weak | Bioventus Inc. | $113k 10,733 shares | -9% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Mar 24, 2025 | BVS Bioventus Inc. | 12,000 0.02% of outstanding | $118k | Mar 24, 2025 | $179k |
| Dec 23, 2024 | BVS Bioventus Inc. | 19,000 0.03% of outstanding | $212k | Dec 23, 2024 | none |
Transactions
Every row this insider has filed, 28 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 10, 2026 | BVS Bioventus Inc. | MOption exercise Class A Common Stock | +13,000 | $0.00 | $0 | 182,981 | Apr 14, 2026 |
| Apr 10, 2026 | BVS Bioventus Inc. | FTax withholding Class A Common Stock | -5,648 | $9.06 | $51k | 177,333 | Apr 14, 2026 |
| Apr 10, 2026 | BVS Bioventus Inc. | MOption exercise Restricted Stock Unitsderivative | -13,000 | $0.00 | $0 | 13,000 | Apr 14, 2026 |
| Mar 20, 2026 | BVS Bioventus Inc. | MOption exercise Class A Common Stock | +18,625 | $0.00 | $0 | 178,072 | Mar 24, 2026 |
| Mar 20, 2026 | BVS Bioventus Inc. | FTax withholding Class A Common Stock | -8,091 | $8.64 | $70k | 169,981 | Mar 24, 2026 |
| Mar 20, 2026 | BVS Bioventus Inc. | MOption exercise Restricted Stock Unitsderivative | -18,625 | $0.00 | $0 | 0 | Mar 24, 2026 |
| Mar 13, 2026 | BVS Bioventus Inc. | MOption exercise Class A Common Stock | +13,500 | $0.00 | $0 | 165,312 | Mar 17, 2026 |
| Mar 13, 2026 | BVS Bioventus Inc. | FTax withholding Class A Common Stock | -5,865 | $8.62 | $51k | 159,447 | Mar 17, 2026 |
| Mar 14, 2025 | BVS Bioventus Inc. | AGrant or award Restricted Stock Unitsderivative | +54,000 | $0.00 | $0 | 54,000 | Mar 17, 2026 |
| Mar 14, 2025 | BVS Bioventus Inc. | AGrant or award Stock Option (Right to Buy)derivative | +61,000 | $0.00 | $0 | 61,000 | Mar 17, 2026 |
| Mar 13, 2026 | BVS Bioventus Inc. | AGrant or award Restricted Stock Unitsderivative | +104,000 | $0.00 | $0 | 104,000 | Mar 17, 2026 |
| Mar 13, 2026 | BVS Bioventus Inc. | AGrant or award Stock Option (Right to Buy)derivative | +116,000 | $0.00 | $0 | 116,000 | Mar 17, 2026 |
| Mar 13, 2026 | BVS Bioventus Inc. | MOption exercise Restricted Stock Unitsderivative | -13,500 | $0.00 | $0 | 40,500 | Mar 17, 2026 |
| Feb 15, 2026 | BVS Bioventus Inc. | MOption exercise Class A Common Stock | +20,153 | $0.00 | $0 | 161,241 | Feb 18, 2026 |
| Feb 15, 2026 | BVS Bioventus Inc. | FTax withholding Class A Common Stock | -9,429 | $8.27 | $78k | 151,812 | Feb 18, 2026 |
| Feb 15, 2026 | BVS Bioventus Inc. | MOption exercise Restricted Stock Unitsderivative | -20,153 | $0.00 | $0 | 40,304 | Feb 18, 2026 |
| Apr 11, 2025 | BVS Bioventus Inc. | SOpen-market sale Class A Common Stock10b5-1 | -3,875 | $7.57 | $29k | 141,088 | Apr 15, 2025 |
| Apr 10, 2025 | BVS Bioventus Inc. | MOption exercise Class A Common Stock | +13,000 | $0.00 | $0 | 144,963 | Apr 11, 2025 |
| Apr 10, 2025 | BVS Bioventus Inc. | MOption exercise Restricted Stock Unitsderivative | -13,000 | $0.00 | $0 | 26,000 | Apr 11, 2025 |
| Mar 24, 2025 | BVS Bioventus Inc. | SOpen-market sale Class A Common Stock10b5-1 | -5,479 | $9.79 | $54k | 131,963 | Mar 25, 2025 |
| Mar 21, 2025 | BVS Bioventus Inc. | MOption exercise Class A Common Stock | +18,625 | $0.00 | $0 | 137,442 | Mar 21, 2025 |
| Mar 21, 2025 | BVS Bioventus Inc. | MOption exercise Restricted Stock Unitsderivative | -18,625 | $0.00 | $0 | 18,625 | Mar 21, 2025 |
| Feb 18, 2025 | BVS Bioventus Inc. | SOpen-market sale Class A Common Stock10b5-1 | -6,498 | $10.19 | $66k | 118,817 | Feb 20, 2025 |
| Feb 15, 2025 | BVS Bioventus Inc. | MOption exercise Class A Common Stock | +20,153 | $0.00 | $0 | 125,315 | Feb 18, 2025 |
| Feb 15, 2025 | BVS Bioventus Inc. | MOption exercise Restricted Stock Unitsderivative | -20,153 | $0.00 | $0 | 60,457 | Feb 18, 2025 |
| Dec 23, 2024 | BVS Bioventus Inc. | SOpen-market sale Class A Common Stock10b5-1 | -10,733 | $10.53 | $113k | 105,162 | Dec 26, 2024 |
| Dec 20, 2024 | BVS Bioventus Inc. | MOption exercise Class A Common Stock | +31,000 | $0.00 | $0 | 115,895 | Dec 23, 2024 |
| Dec 20, 2024 | BVS Bioventus Inc. | MOption exercise Restricted Stock Unitsderivative | -31,000 | $0.00 | $0 | 0 | Dec 23, 2024 |
Questions about Mark Leonard Singleton
Answered from the filings on this page, as of the latest one.
Is Mark Leonard Singleton buying or selling?
Not in the last 12 months. Mark Leonard Singleton's latest open-market trade on SEC Form 4 was sold $29k of BVS on Apr 11, 2025.
How did Mark Leonard Singleton's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Mark Leonard Singleton has 0.
Where does Mark Leonard Singleton file Form 4?
Mark Leonard Singleton has filed Form 4 at BVS (Bioventus Inc.) as SVP & CFO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.